GlassScriptPhysician profile
Joven P Dungo
NPI 1386726230
$103,549.13
in general payments reported to CMS, 2019-2025
61 companies · $8,858 in 2025
The $8,858 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,861 · 2020: $4,995 · 2021: $56K · 2022: $8,339 · 2023: $8,713 · 2024: $9,568 · 2025: $8,858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $27K · Education: $71.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $27,067.40 |
| Education | $71.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $57,073.26 | 2019-2025 | Jot Dx, Aveir, Cardiomems |
| Astrazeneca Pharmaceuticals LP | $6,191.37 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $4,841.40 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $3,448.54 | 2019-2025 | Arexvy, Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $3,204.60 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $2,350.01 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Edwards Lifesciences Corporation | $2,297.24 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbvie INC. | $1,950.60 | 2019-2025 | Linzess, Creon, Viberzi |
| Intra-Sana Laboratories | $1,943.23 | 2024-2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Horizon Therapeutics Plc | $1,776.59 | 2019-2023 | Krystexxa |
| Amgen INC. | $1,629.29 | 2019-2025 | Krystexxa, Repatha, Repatha |
| Corcept Therapeutics | $1,627.34 | 2022-2025 | Korlym |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,549.00 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $1,264.13 | 2019-2025 | Verquvo, Steglatro, Capvaxive |
| Neurocrine Biosciences, INC. | $1,179.74 | 2020-2023 | Ingrezza |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $865.14 | 2019-2025 | Xifaxan, Trulance, Relistor |
| Ani Pharmaceuticals, INC. | $771.05 | 2023-2025 | Purified Cortrophin Gel |
| Ironwood Pharmaceuticals, INC | $727.59 | 2019-2024 | Linzess |
| Lilly USA, LLC | $646.91 | 2019-2023 | Jardiance, Emgality, Mounjaro |
| Novartis Pharmaceuticals Corporation | $625.48 | 2019-2025 | |
| Medtronic, INC. | $607.15 | 2021-2025 | Cobalt Dr Mri Surescan, Endurant Iis, Symplicity G3 |
| Allergan, INC. | $600.87 | 2019-2020 | |
| Boston Scientific Corporation | $548.42 | 2019-2024 | Watchman Flx, Watchman, Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $505.08 | 2019-2024 | Camzyos |
| Vivus LLC | $381.33 | 2021-2025 | Qsymia, Pancreaze |
| Cardiovascular Systems INC. | $376.37 | 2019-2020 | |
| Medtronic Vascular, INC. | $329.48 | 2019-2020 | |
| Pfizer INC. | $321.23 | 2019-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $306.37 | 2022 | |
| Acorda Therapeutics, INC | $253.33 | 2019 | |
| Axsome Therapeutics, INC. | $250.77 | 2025 | Symbravo |
| Philips North America LLC | $222.55 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $201.44 | 2025 | |
| Inari Medical, INC. | $194.91 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Gilead Sciences, INC. | $182.48 | 2019-2020 | |
| Zoll Circulation INC | $162.43 | 2024 | Downstream Cartridge, Therox Ds2 Console, Catheter |
| Abiomed | $161.27 | 2019 | |
| Cvrx, INC. | $160.33 | 2025 | Barostim Neo System |
| Shockwave Medical, INC | $148.71 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Impulse Dynamics (USA) INC. | $135.34 | 2024 | Optimizer |
| Amarin Pharma, INC. | $126.94 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $125.02 | 2025 | Voquezna |
| Viiv Healthcare Company | $125.00 | 2025 | Apretude |
| Biohaven Pharmaceuticals, INC. | $125.00 | 2021 | |
| Biotronik INC. | $118.40 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $117.21 | 2019 | |
| W. L. Gore & Associates, INC. | $116.89 | 2022 | |
| Sanofi-Aventis U.S. LLC | $85.54 | 2019-2022 | |
| Smith+Nephew, INC. | $71.18 | 2023-2024 | Collagenase Santyl |
| Xeris Pharmaceuticals, INC. | $66.33 | 2025 | Recorlev |
| Scilex Pharmaceuticals INC. | $66.02 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $64.54 | 2024 | Acthar |
| Hikma Pharmaceuticals USA | $63.54 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $62.37 | 2020-2021 | |
| Heartflow, INC. | $60.86 | 2024 | |
| Redhill Biopharma INC. | $42.16 | 2020-2021 | |
| Eyevance Pharmaceuticals LLC | $25.42 | 2021 | |
| Astellas Pharma US INC | $21.54 | 2024 | Veozah |
| Ars Pharmaceuticals Operations, INC. | $19.40 | 2025 | Neffy |
| Lexicon Pharmaceuticals, INC. | $17.90 | 2024 | |
| Exact Sciences Corporation | $15.50 | 2025 | The Cologuard Plus Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joven Dungo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.